Trademark: 85852462
Word
APLLEVO
Status
Dead
Status Code
606
Status Date
Monday, September 29, 2014
Serial Number
85852462
Mark Type
4000
Filing Date
Monday, February 18, 2013
Published for Opposition
Tuesday, July 2, 2013
Abandoned Date
Monday, September 29, 2014

Trademark Owner History
Eli Lilly and Company - Owner At Publication

Classifications
5 Pharmaceutical preparations, namely, pharmaceutical preparations for the diagnosis and treatment of alcohol use disorders, Alzheimer's, anxiety disorders, atherosclerosis, autoimmune diseases and disorders, blood disorders, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cholesterol disorders, cystic fibrosis, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hormonal diseases and disorders, inflammation and inflammatory diseases and disorders, kidney diseases and disorders, liver diseases and disorders, metabolic diseases and disorders, migraines, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, obesity, pain, pancreatic diseases and disorders, psychiatric disorders, reproductive system diseases and disorders, sleep disorders, urological disorders; antidepressants

Trademark Events
Sep 29, 2014
Abandonment Notice Mailed - No Use Statement Filed
Sep 29, 2014
Abandonment - No Use Statement Filed
Feb 25, 2014
Noa E-Mailed - Sou Required From Applicant
Jan 14, 2014
Extension Of Time To Oppose Process - Terminated
Jul 31, 2013
Extension Of Time To Oppose Received
Jul 2, 2013
Official Gazette Publication Confirmation E-Mailed
Jul 2, 2013
Published For Opposition
Jun 12, 2013
Notification Of Notice Of Publication E-Mailed
May 28, 2013
Approved For Pub - Principal Register
May 23, 2013
Assigned To Examiner
Feb 26, 2013
New Application Office Supplied Data Entered In Tram
Feb 21, 2013
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24